alfuzosin and tamsulosin

alfuzosin has been researched along with tamsulosin in 92 studies

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (10.87)18.2507
2000's43 (46.74)29.6817
2010's36 (39.13)24.3611
2020's3 (3.26)2.80

Authors

AuthorsStudies
Ballard, S; Blagg, J; Fox, D; Kenny, B1
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Condon, S; Drizin, I; Elmore, SW; Hancock, AA; Kerwin, JF; Meyer, MD; Sippy, KB; Tietje, K; Wendt, MD1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD1
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG1
Chalmers, DH; Kenny, BA; Miller, AM; Naylor, AM; O'Connell, J; Williamson, IJ1
Andersson, KE; Lepor, H; Wyllie, MG1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I1
Buzelin, JM; Fonteyne, E; Khan, A; Kontturi, M; Witjes, WP1
Chapple, CR1
Bèïque, L; Evans, MF; Por, CP1
Claes, H; De Reijke, TM; Folkestad, B; Höfner, K; Speakman, MJ1
Clifford, GM; Farmer, RD1
de la ROSETTE, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS; Wijkstra, H1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC1
Dutkiewics, S1
Flannery, MT; Michel, MC; Narayan, P1
Chess-Williams, R1
de la Rosette, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS1
Romics, I1
Alexandre, L; Allard, J; Bernabe, J; Droupy, S; Giuliano, F1
Michel, MC1
Dessi, C; Marchese, G; Mongeau, R; Pani, L; Ruiu, S; Tambaro, S1
Lowe, FC1
Kähönen, M; Kööbi, T; Nieminen, T; Ylitalo, P; Ylitalo, R1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E1
Nordling, J1
Arunkalaivanan, A; Sinha, D1
Afshari, NA; Schwinn, DA1
Egilmez, T; Guvel, S; Kilinc, F; Ozkardes, H; Pourbagher, MA; Turunc, T1
Irani, J1
Nagano, M; Osada, Y; Yamaguchi, T1
Chapple, CR; Michel, MC1
Artibani, W; Calpista, A; Cisternino, A; De Marco, V; Iafrate, M; Prayer Galetti, T; Zeccolini, G1
de la Rosette, JJ; Michel, MC; van Dijk, MM1
O'Leary, MP1
Alexandre, L; Bernabé, J; Clément, P; Denys, P; Giuliano, FA1
Lowe, FC; Santillo, VM1
Hellstrom, WJ; Sikka, SC1
Osaghae, S1
Adibelli, FM; Akova, YA; Altan-Yaycioglu, R; Gul, U; Pelit, A; Yaycioglu, O1
Awan, MA; Cheung, CM; Peh, KK; Sandramouli, S1
Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S1
Noguchi, Y; Ohtake, A; Sasamata, M; Suzuki, M1
Chang, DF; Lluel, P; Palea, S; Regnier, A; Rekik, M1
Arikan, G; Bozkurt, O; Demir, O; Durak, I; Esen, A; Saatci, AO; Yaman, A1
Mamalis, N1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ1
Agrawal, A; Agrawal, M; Gupta, A; Gupta, M; Lavania, P; Sarkari, A1
Chatterjee, M; Gupta, D; Gupta, S; Nanda, K; Ray, A; Singh, R; Tiwar, A1
Subramonian, K; Zeif, HJ1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA1
Chung, BH; Lee, SH; Mah, SY; Park, KK1
Chatziralli, IP; Sergentanis, TN1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H1
Atahan, Ö; Budak, YU; Karadağ, E; Öner, S1
Du, H; He, L; Ren, J; Wang, S1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW1
Achtsidis, V; Fountas, KN; Komninos, C; Tentolouris, N; Theodoropoulou, S; Theodossiadis, PG1
Hoyano, Y; Kobayashi, K; Kobayashi, M; Kuroda, J; Kusama, H; Maruyama, K; Tatemichi, S; Yokoi, R1
Lee, HJ; Lee, JW1
Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J1
Kujala, PM; Murtola, TJ; Tammela, TL1
Carrillo-Ruiz, JD; González-Valle, JC; Guzman-Esquivel, J; Labra-Salgado, IR; Maldonado-Ávila, M; Manzanilla-García, HA; Rosas-Nava, E; Sierra-Ramírez, JA1
Campbell, JR; Chang, DF; Colin, J; Schweitzer, C1
Aktas, Z; Ceylan, G; Hasanreisoglu, B; Hasanreisoglu, M; Polat, F; Yuksel, N1
Fisher, E; Omar, MI; Subramonian, K1
Kara, O; Yazici, M1
Altay, AB; Apaydin, E; Bademkiran, F; Cikili, N; Semerci, MB; Turna, B; Umul, M1
Cho, KS; Choi, YD; Ham, WS; Kang, DH; Kwon, JK; Lee, H; Lee, JY; Oh, CK1
Chen, K; Kang, R; Li, J; Liu, C; Wan, SP; Wu, W; Zeng, G1
Barkin, J; Berner, T; Diles, D; Franks, B1
Dixon, S; Fraser, LA; Hayward, J; Hwang, YJ; McArthur, E; Ordon, M; Welk, B1
Armarnik, S; Assia, EI; Mimouni, M; Rosen, E; Segev, F1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C1
Adamo, EB; Altavilla, D; Crea, G; Irrera, N; Lorenzini, C; Marini, H; Micali, A; Minutoli, L; Pisani, A; Puzzolo, D; Rinaldi, M; Squadrito, F; Valenti, A1
Allenet, B; Bedouch, P; Bensalah, N; Charpiat, B; Conort, O; Garcia, S; Juste, M; Rose, FX; Roubille, R; Tod, M1
Dogan, M; Halat, AO; Karalar, M; Keles, I; Kutluksaman, B1
Akkoc, A; Aydin, C; Baykam, MM; Ekici, M; Sentürk, AB; Yaytokgil, M1
Afsar Yildirim, M; Akdeniz, F; Bozkurt, O; Çelik, S; Demir, O; Gursoy Bulut, M; Hacihasanoglu, ML1
Chen, Y; Jian, Z; Li, H; Liao, B; Liu, Q; Wang, K; Yang, T1
Belal, F; Borg, H; Fathy, M; Walash, MI; Zayed, S1
Bourdoumis, A; Buchholz, N; Dräger, D; Durner, L; Füllhase, C; Hakenberg, OW1
Miernik, A; Praus, F1
Hori, Y; Ohyama, K; Sugiura, M1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ1
Hartikainen, S; Latvala, L; Murtola, TJ; Tiihonen, M; Tolppanen, AM1

Reviews

27 review(s) available for alfuzosin and tamsulosin

ArticleYear
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Prostatic alpha 1-adrenoceptors and uroselectivity.
    The Prostate, 1997, Feb-15, Volume: 30, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Revista clinica espanola, 1997, Volume: 197, Issue:5

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1997
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
    British journal of urology, 1998, Volume: 81 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1998
Medical therapy for benign prostatic hyperplasia: a review of the literature.
    European urology, 2000, Volume: 38, Issue:1

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2000
Worldwide experience with alfuzosin and tamsulosin.
    Urology, 2001, Volume: 58, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Controlled Clinical Trials as Topic; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urodynamics

2001
The use of alpha-adrenoceptor antagonists in lower urinary tract disease.
    Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:2

    Topics: Adrenergic alpha-Antagonists; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urologic Diseases

2002
[Pharmacologic treatment of benign prostatic hyperplasia].
    Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2003
Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Tract; Urologic Diseases

2004
Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
    Drugs, 2006, Volume: 66, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Aged; Doxazosin; Ejaculation; Erectile Dysfunction; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

2006
Treatment and pharmacologic management of BPH in the context of common comorbidities.
    The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome

2006
The management of chronic prostatitis in men with HIV.
    Current urology reports, 2006, Volume: 7, Issue:4

    Topics: Adrenergic alpha-Antagonists; Algorithms; Antiretroviral Therapy, Highly Active; Chronic Disease; Comorbidity; Cystoscopy; HIV Infections; Humans; Male; Pelvic Pain; Prostatitis; Quercetin; Quinazolines; Sulfonamides; Tamsulosin; Urodynamics

2006
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].
    Harefuah, 2008, Volume: 147, Issue:6

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2008
Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Device Removal; Humans; Male; Quinazolines; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination

2009
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
    Ophthalmology, 2011, Volume: 118, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin

2011
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.
    Current medical research and opinion, 2013, Volume: 29, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2013
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
    The Cochrane database of systematic reviews, 2014, Jun-10, Issue:6

    Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Device Removal; Doxazosin; Humans; Indoles; Male; Quinazolines; Randomized Controlled Trials as Topic; Recovery of Function; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination

2014
The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo.
    BMC urology, 2015, Jun-24, Volume: 15

    Topics: Adrenergic alpha-Antagonists; Bayes Theorem; Humans; Pain; Pain Measurement; Quinazolines; Randomized Controlled Trials as Topic; Stents; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Obstruction

2015
Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Humans; Quinazolines; Sulfonamides; Tamsulosin; Ureter; Ureteral Calculi; Urological Agents

2015
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
    European urology, 2016, Volume: 69, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics

2016
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.
    International journal of molecular sciences, 2016, Aug-11, Volume: 17, Issue:8

    Topics: Apoptosis; Dutasteride; Endocrine System; Finasteride; Humans; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urological Agents

2016
[How to act when an alpha-blocker is associated with a potent inhibitor of CYP3A4].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2017, Volume: 27, Issue:5

    Topics: Adrenergic alpha-Antagonists; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; France; Government Agencies; Humans; Indoles; Ketoconazole; Quinazolines; Sulfonamides; Tamsulosin

2017
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
    World journal of urology, 2019, Volume: 37, Issue:2

    Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinazolines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urological Agents

2019
The Evidence Paradox of the Effectiveness between the Paediatric and Adult Stone-Forming Population: A Narrative Review.
    Urologia internationalis, 2019, Volume: 102, Issue:2

    Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Age of Onset; Child; Doxazosin; Evidence-Based Medicine; Female; Humans; Male; Quinazolines; Remission Induction; Tamsulosin; Treatment Outcome; Urolithiasis; Urological Agents

2019
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
    Der Urologe. Ausg. A, 2019, Volume: 58, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents

2019
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
    The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi

2020

Trials

16 trial(s) available for alfuzosin and tamsulosin

ArticleYear
Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.
    British journal of urology, 1997, Volume: 80, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urination

1997
Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia?
    Canadian family physician Medecin de famille canadien, 1998, Volume: 44

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Double-Blind Method; Humans; Hypotension; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1998
Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    European urology, 1999, Volume: 36, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Incidence; Libido; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Obstruction

1999
The vasodilatory effect of alfuzosin and tamsulosin in passive orthostasis: a randomised, double-blind, placebo-controlled study.
    European urology, 2005, Volume: 47, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Dizziness; Double-Blind Method; Female; Head-Down Tilt; Hemodynamics; Humans; Male; Quinazolines; Sulfonamides; Supine Position; Tamsulosin; Vasodilator Agents

2005
Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.
    BJU international, 2005, Volume: 95, Issue:7

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders

2005
Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).
    European urology, 2006, Volume: 49, Issue:3

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Age Factors; Aged; Blood Pressure; Cross-Over Studies; Delayed-Action Preparations; Dizziness; Humans; Male; Middle Aged; Phenylephrine; Quinazolines; Sulfonamides; Tamsulosin; Vascular Resistance

2006
Obstructive primary bladder neck disease: evaluation of the efficacy and safety of alpha1-blockers.
    Urologia internationalis, 2006, Volume: 76, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Humans; Male; Middle Aged; Quinazolines; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction

2006
Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.
    The Journal of urology, 2006, Volume: 176, Issue:4 Pt 1

    Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Drug Administration Schedule; Ejaculation; Humans; Male; Quinazolines; Sperm Count; Sulfonamides; Tamsulosin; Urine

2006
The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Single-Blind Method; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Visual Acuity

2007
Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones.
    Urology, 2009, Volume: 73, Issue:4

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Female; Humans; Male; Middle Aged; Prospective Studies; Quinazolines; Sulfonamides; Tamsulosin; Ureteral Calculi; Young Adult

2009
Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia.
    International urology and nephrology, 2011, Volume: 43, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Over Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Quality of Life; Quinazolines; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Treatment Outcome

2011
A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth.
    International urology and nephrology, 2014, Volume: 46, Issue:4

    Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Aged; Device Removal; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Recovery of Function; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination

2014
Prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin.
    Ophthalmology, 2014, Volume: 121, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Sectional Studies; Double-Blind Method; Humans; Intraoperative Complications; Iris Diseases; Lens Implantation, Intraocular; Male; Phacoemulsification; Prolapse; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Risk Factors; Severity of Illness Index; Sulfonamides; Tamsulosin; Video Recording

2014
The effects of tamsulosin and alfuzosin on iris morphology: an ultrasound biomicroscopic comparison.
    Cutaneous and ocular toxicology, 2015, Volume: 34, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Iris; Male; Middle Aged; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography

2015
Is the double dose alpha-blocker treatment superior than the single dose in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia?
    Urology journal, 2014, Jul-08, Volume: 11, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Dizziness; Drug Therapy, Combination; Headache; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Retention

2014
The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia.
    Current eye research, 2017, Volume: 42, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Choroid; Color Vision; Diagnostic Techniques, Ophthalmological; Humans; Iris; Male; Middle Aged; Night Vision; Organ Size; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Tamsulosin; Tomography, Optical Coherence

2017

Other Studies

49 other study(ies) available for alfuzosin and tamsulosin

ArticleYear
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH).
    Journal of medicinal chemistry, 2000, Apr-20, Volume: 43, Issue:8

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cell Line; Dogs; Heterocyclic Compounds, 3-Ring; Indoles; Male; Pressure; Prostatic Hyperplasia; Radioligand Assay; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Urethra

2000
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens

2001
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Urology, 1994, Volume: 44, Issue:1

    Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin

1994
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    British journal of pharmacology, 1996, Volume: 118, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Pressure; Prostate; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

1996
The missing alpha blocker paper.
    British journal of urology, 1997, Volume: 80, Issue:2

    Topics: Adrenergic alpha-Antagonists; Authorship; Humans; Publication Bias; Quinazolines; Sulfonamides; Tamsulosin

1997
alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.
    The Journal of urology, 2001, Volume: 165, Issue:1

    Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prazosin; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urodynamics

2001
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium

2001
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.
    Journal of clinical epidemiology, 2001, Volume: 54, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin

2001
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.
    International urology and nephrology, 2001, Volume: 32, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2001
Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.
    The Journal of urology, 2002, Volume: 167, Issue:4

    Topics: Adrenergic beta-Antagonists; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Time Factors; Treatment Failure

2002
A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats.
    BJU international, 2004, Volume: 93, Issue:4

    Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Ejaculation; Evoked Potentials; Male; Muscle Contraction; Pressure; Quinazolines; Rats; Rats, Wistar; Seminal Vesicles; Sulfonamides; Tamsulosin; Urinary Bladder

2004
Ejaculatory dysfunction and alpha-adrenoceptor antagonists.
    BJU international, 2004, Volume: 94, Issue:3

    Topics: Adrenergic alpha-Antagonists; Ejaculation; Erectile Dysfunction; Humans; Male; Quinazolines; Sulfonamides; Tamsulosin

2004
Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Ejaculation; Electric Stimulation; Epididymis; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Quinazolines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Vas Deferens; Vasoconstrictor Agents

2005
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics

2004
Urethral syndrome: response to alpha-adrenergic blocking agents.
    International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; Sulfonamides; Syndrome; Tamsulosin; Urinary Bladder, Overactive

2006
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
    Ophthalmology, 2005, Volume: 112, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2005
Effects of selective alpha-1-adrenergic receptor blockers on bladder weight.
    Urologia internationalis, 2006, Volume: 76, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Hypertrophy; Male; Middle Aged; Organ Size; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography; Urinary Bladder

2006
Are all alpha-blockers created the same?
    European urology, 2006, Volume: 49, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Clinical Trials as Topic; Dizziness; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2006
Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2005, Volume: 41, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiovascular System; Male; Phenylephrine; Prazosin; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra

2005
Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats.
    BJU international, 2006, Volume: 98, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Ejaculation; Male; Muscle, Skeletal; Quinazolines; Rats; Rats, Wistar; Serotonin Receptor Agonists; Sulfonamides; Tamsulosin

2006
Re: Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers: W. J. Hellstrom and S. C. Sikka. J Urol 2006; 176: 1529-1533.
    The Journal of urology, 2007, Volume: 177, Issue:4

    Topics: Adrenergic alpha-Antagonists; Ejaculation; Humans; Male; Quinazolines; Sulfonamides; Tamsulosin

2007
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.
    American journal of ophthalmology, 2007, Volume: 143, Issue:6

    Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Doxazosin; Female; Humans; Hypertension; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2007
Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Odds Ratio; Phacoemulsification; Postoperative Complications; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Risk Factors; Sulfonamides; Syndrome; Tamsulosin

2007
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    European journal of pharmacology, 2008, Feb-02, Volume: 580, Issue:1-2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Ejaculation; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin; Urethra; Vas Deferens

2008
Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.
    Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Intraoperative Complications; Iris; Iris Diseases; Male; Muscle, Smooth; Phenylephrine; Prostate; Quinazolines; Rabbits; Sulfonamides; Sympathomimetics; Syndrome; Tamsulosin

2008
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.
    Annals of ophthalmology (Skokie, Ill.), 2008,Spring, Volume: 40, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
    Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2008
Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.
    Biotechnology journal, 2009, Volume: 4, Issue:3

    Topics: Animals; Biotechnology; Calcium; Cell Line; Dose-Response Relationship, Drug; Fluorescent Dyes; Fluorometry; GTP-Binding Proteins; Humans; Kinetics; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic; Signal Transduction; Sulfonamides; Tamsulosin

2009
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    The Journal of urology, 2010, Volume: 183, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin

2010
Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.
    Prostate cancer and prostatic diseases, 2010, Volume: 13, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Models, Biological; Polypharmacy; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin

2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.
    Urology, 2011, Volume: 77, Issue:6

    Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography

2011
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.
    Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

2011
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.
    Journal of pharmacy practice, 2012, Volume: 25, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin

2012
The effect of alpha antagonists on pupil dynamics: implications for the diagnosis of intraoperative floppy iris syndrome.
    American journal of ophthalmology, 2012, Volume: 153, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Case-Control Studies; Cataract Extraction; Diagnostic Techniques, Ophthalmological; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle Hypotonia; Muscle, Smooth; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Tamsulosin

2012
Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.
    Urology, 2012, Volume: 80, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Indoles; Male; Naphthalenes; Piperazines; Quinazolines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin

2012
Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma.
    Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Finasteride; Glaucoma; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Vision Disorders

2013
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
    The Prostate, 2013, Volume: 73, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cohort Studies; Disease-Free Survival; Dutasteride; Finasteride; Finland; Humans; Kallikreins; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quinazolines; Sulfonamides; Survival Rate; Tamsulosin

2013
The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity.
    Turkish journal of medical sciences, 2014, Volume: 44, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Autonomic Nervous System; Blood Glucose; Body Mass Index; Erectile Dysfunction; Humans; Lipids; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Testosterone

2014
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
    The Canadian journal of urology, 2015, Volume: 22, Issue:4

    Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate

2015
The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study.
    BMJ (Clinical research ed.), 2015, Oct-26, Volume: 351

    Topics: Accidental Falls; Adrenergic alpha-1 Receptor Antagonists; Aged; Canada; Craniocerebral Trauma; Fractures, Bone; Humans; Hypotension; Indoles; Male; Outcome Assessment, Health Care; Prostate; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Risk Factors; Sulfonamides; Tamsulosin

2015
Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016, Volume: 254, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cornea; Drug Combinations; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin

2016
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    The Prostate, 2016, Volume: 76, Issue:8

    Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin

2016
Comparison of three most frequently used alpha blocker agents in medical expulsive therapy for distal ureteral calculi, result of a retrospective observational study.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2018, Mar-31, Volume: 90, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Analgesics; Drug Combinations; Drug Utilization; Female; Humans; Indoles; Male; Middle Aged; Quinazolines; Retrospective Studies; Tamsulosin; Ureteral Calculi; Young Adult

2018
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2018, Jun-30, Volume: 90, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Doxazosin; Female; Flank Pain; Humans; Indoles; Male; Middle Aged; Quinazolines; Retrospective Studies; Tadalafil; Tamsulosin; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult

2018
Simultaneous HPLC determination of alfuzosin, tamsulosin and vardenafil in human plasma and pharmaceutical formulations using time programmed fluorescence detection.
    Annales pharmaceutiques francaises, 2019, Volume: 77, Issue:1

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Chromatography, High Pressure Liquid; Drug Compounding; Humans; Male; Prostatic Hyperplasia; Quinazolines; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Tamsulosin; Vardenafil Dihydrochloride; Vasodilator Agents

2019
Evaluation of syncope association with α
    Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin

2019
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.
    JAMA neurology, 2021, 04-01, Volume: 78, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States

2021
Use of α1-adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease.
    Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:10

    Topics: Adrenergic alpha-Antagonists; Alzheimer Disease; Case-Control Studies; Humans; Male; Quinazolines; Receptors, Adrenergic; Sulfonamides; Tamsulosin

2022